Reply to 'Paracetamol use in pregnancy - neglecting context promotes misinterpretation'

Ann Z Bauer¹, Shanna H Swan², David Kriebel¹, Zeyan Liew³, Hugh S Taylor⁴, Carl-Gustaf Bornehag^{2

5}, Anderson M Andrade⁶, Jørn Olsen⁷, Rigmor H Jensen⁸, Rod T Mitchell⁹, Niels E Skakkebaek¹⁰, David M Kristensen^{11

12

13}

Affiliations

¹ Department of Public Health, University of Massachusetts Lowell, Lowell, MA, USA.
² Department of Environmental Medicine and Public Health, Icahn School of Medicine at Mount Sinai, New York City, NY, USA.
³ Yale Center for Perinatal, Pediatric, and Environmental Epidemiology, Yale School of Public Health, New Haven, CT, USA.
⁴ Department of Obstetrics, Gynecology and Reproductive Sciences, Yale School of Medicine, Yale-New Haven Hospital, New Haven, CT, USA.
⁵ Department of Health Sciences, Karlstad University, Karlstad, Sweden.
⁶ Departamento de Fisiologia, Setor de Ciências Biológicas, UFPR, Curitiba, Brazil.
⁷ Department of Public Health, Aarhus University, Aarhus, Denmark.
⁸ Department of Neurology, Danish Headache Center, Rigshospitalet-Glostrup, University of Copenhagen, Copenhagen, Denmark.
⁹ MRC Centre for Reproductive Health, Queens Medical Research Institute, Edinburgh, UK.
¹⁰ Department of Growth & Reproduction and EDMaRC, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
¹¹ Department of Neurology, Danish Headache Center, Rigshospitalet-Glostrup, University of Copenhagen, Copenhagen, Denmark. david@moebjerg.com.
¹² Univ Rennes, Inserm, EHESP, Irset, Rennes, France. david@moebjerg.com.
¹³ Department of Biology, University of Copenhagen, Copenhagen, Denmark. david@moebjerg.com.

Comment

Ann Z Bauer et al. Nat Rev Endocrinol. 2022 Jun.

. 2022 Jun;18(6):386.

doi: 10.1038/s41574-022-00657-8.

¹ Department of Public Health, University of Massachusetts Lowell, Lowell, MA, USA.
² Department of Environmental Medicine and Public Health, Icahn School of Medicine at Mount Sinai, New York City, NY, USA.
³ Yale Center for Perinatal, Pediatric, and Environmental Epidemiology, Yale School of Public Health, New Haven, CT, USA.
⁴ Department of Obstetrics, Gynecology and Reproductive Sciences, Yale School of Medicine, Yale-New Haven Hospital, New Haven, CT, USA.
⁵ Department of Health Sciences, Karlstad University, Karlstad, Sweden.
⁶ Departamento de Fisiologia, Setor de Ciências Biológicas, UFPR, Curitiba, Brazil.
⁷ Department of Public Health, Aarhus University, Aarhus, Denmark.
⁸ Department of Neurology, Danish Headache Center, Rigshospitalet-Glostrup, University of Copenhagen, Copenhagen, Denmark.
⁹ MRC Centre for Reproductive Health, Queens Medical Research Institute, Edinburgh, UK.
¹⁰ Department of Growth & Reproduction and EDMaRC, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
¹¹ Department of Neurology, Danish Headache Center, Rigshospitalet-Glostrup, University of Copenhagen, Copenhagen, Denmark. david@moebjerg.com.
¹² Univ Rennes, Inserm, EHESP, Irset, Rennes, France. david@moebjerg.com.
¹³ Department of Biology, University of Copenhagen, Copenhagen, Denmark. david@moebjerg.com.

No abstract available

Comment on

Paracetamol use during pregnancy - a call for precautionary action.
Bauer AZ, Swan SH, Kriebel D, Liew Z, Taylor HS, Bornehag CG, Andrade AM, Olsen J, Jensen RH, Mitchell RT, Skakkebaek NE, Jégou B, Kristensen DM. Bauer AZ, et al. Nat Rev Endocrinol. 2021 Dec;17(12):757-766. doi: 10.1038/s41574-021-00553-7. Epub 2021 Sep 23. Nat Rev Endocrinol. 2021. PMID: 34556849 Free PMC article. Review.
Paracetamol use in pregnancy - neglecting context promotes misinterpretation.
O'Sullivan J, Cairns AE, Plesca E, Black RS, Frise C, Vatish M, Cerdeira AS. O'Sullivan J, et al. Nat Rev Endocrinol. 2022 Jun;18(6):385. doi: 10.1038/s41574-022-00656-9. Nat Rev Endocrinol. 2022. PMID: 35277662 No abstract available.

1. Bauer, A. Z. et al. Paracetamol use during pregnancy — a call for precautionary action. Nat. Rev. Endocrinol. 17, 757–766 (2021). - DOI
1. O’Sullivan, J. et al. Paracetamol in pregnancy — neglecting context promotes misinterpretation. Nat. Rev. Endocrinol. https://doi.org/10.1038/s41574-022-00656-9 (2022).
1. European Medicines Agency. PRAC recommendations on signals: adopted at the 12–15 March 2019 PRAC meeting. https://www.ema.europa.eu/en/documents/prac-recommendation/prac-recommen... (2019).
1. Food and Drug Administration. FDA Drug Safety Communications: FDA has reviewed possible risks of pain medicine use during pregnancy. https://www.fda.gov/media/90209/download (2015).